Myristica malabarica heals stomach ulceration by increasing prostaglandin synthesis and angiogenesis

Planta Medica

Volumn 74, Issue 15, 2008, Pages 1774-1778

  Maity, Biswanath ^a   Banerjee, Debashish ^a   Bandyopadhyay, Sandip K ^a   Chattopadhyay, Subrata ^b  

^a Dr BC Roy Post Graduate Institute of Basic Medical Sciences   (India)

^b BHABHA ATOMIC RESEARCH CENTRE   (India)

Author keywords

Angiogenesis; Gastrointestinal ulceration; Myristica malabarica; Myristicaceae; PGE2

Indexed keywords

ENDOSTATIN; EPIDERMAL GROWTH FACTOR; INDOMETACIN; MYRISTICA MALABARICA EXTRACT; OMEPRAZOLE; PLANT EXTRACT; PROSTAGLANDIN E2; UNCLASSIFIED DRUG; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; HISTOPATHOLOGY; MALE; MOUSE; MYRISTICA MALABARICA; MYRISTICACEAE; NONHUMAN; PARAMETER; PROSTAGLANDIN SYNTHESIS; QUANTITATIVE ASSAY; REGULATORY MECHANISM; SCORING SYSTEM; STOMACH ULCER; TISSUE LEVEL; ULCER HEALING;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTI-ULCER AGENTS; DINOPROSTONE; ENDOSTATINS; EPIDERMAL GROWTH FACTOR; FRUIT; GASTRIC MUCOSA; INDOMETHACIN; MALE; MICE; MYRISTICACEAE; NEOVASCULARIZATION, PHYSIOLOGIC; OMEPRAZOLE; OXYTOCICS; PHYTOTHERAPY; PLANT EXTRACTS; STOMACH ULCER; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VON WILLEBRAND FACTOR;

MUS; MYRISTICA MALABARICA; MYRISTICACEAE;

EID: 58049195140     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0028-1088336     Document Type: Article

References (28)

1. Dr. K. M. Nadkarni's Indian Materia Medica. Mumbai: Popular Prakashan; 1954
2. Palani V, Senthilkumaran RK, Govindasamy S. Biochemical evaluation of antitumor effect of muthu maranthu (a herbal formulation) on experimental fibrosarcoma in rats. J Ethnopharmacol 1999; 65: 257-65.
3. Patro BS, Bauri AK, Mishra S, Chattopadhyay S. Antioxidant activity of Myristica malabarica extracts and their constituents. J Agric Food Chem 2005; 53: 6912-8.
4. Khanom F, Kayahara H, Tadasa K. Superoxide-scavenging and prolyl endopeptidase inhibitory activities of Bangladeshi indigenous medicinal plants. Biosci Biotechnol Biochem 2000; 64: 837-40.
5. Banerjee D, Maity B, Bandyopadhyay SK, Bauri AK, Chattopadhyay S. Gastroprotective properties of Myristica malabarica against indomethacin-induced stomach ulceration: a mechanistic exploration. J Pharm Phamacol 2007; 59: 1555-65.
6. Banerjee D, Bauri AK, Guha RK, Bandyopadhyay SK, Chattopadhyay S. Healing properties of malabaricone B and malabaricone C, against indomethacin-induced gastric ulceration and mechanism of action. Eur J Pharmacol 2008; 578: 300-12
7. Miller TA. Protective effects of prostaglandins against gastric mucosal damage: current knowledge and proposed mechanisms. Am J Physiol 1983; 245: G601-G23.
8. McGrath MH, Emery JMI. The effect of inhibition of angiogenesis in granulation tissue on wound healing and the fibroblast. Ann Plast Surg 1985; 15: 106-19.
9. Ma L, Soldato PD, Wallace JL. Divergent effects of new cyclooxygenase inhibitors on gastric ulcer healing: Shifting the angiogenic balance. Proc Natl Acad Sci USA 2002; 99: 13 243-7.
10. Yokoi K, Thaker PH, Robert SY, Rebhun R, Nam DH, He J et al. Dual inhibition of epidermal growth factor receptor and vascular endothelial growth factor receptor phosphorylation by AEE 788 reduces growth and metastasis of human colon carcinoma in an orthotopic nude mouse model. Cancer Res 2005; 65: 3716-25.
11. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. New Engl J Med 1991; 324: 1-8
12. Wallace JL. Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years. Gastroenterology 1997; 112: 1000-16.
13. Halter F, Schamassman A, Peskar BM, Tarnawski AS. Cyclooxygenase-2 implications on maintenance of gastric mucosal integrity and ulcer healing: controversies and perspectives. Gut 2001; 49: 443-53
14. Jones MK, Wang H, Peskar BM, Levin E, Itani RM, Sarfeh IJ et al. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med 1999; 5: 1418-23
15. Wallace JL. Recent advances in gastric ulcer therapeutics. Curr Opin Pharmacol 2005; 5: 573-7
16. Hassan S, Kinoshita Y, Min D, Nakata H, Kishi K, Matsushima Y et al. Presence of prostaglandin EP4 receptor gene expression in a rat gastric mucosal cell line. Digestion 1996; 57: 196-200
17. Schmassmann A. Mechanisms of ulcer healing and effects of nonsteroidal anti-inflammatory drugs. Am J Med 1998; 104: 43S-51S
18. Coffey RJ, Romano M, Goldenring J. Roles for transforming growth factor-alpha in the stomach. J Clin Gastroenterol 1995; 21: S36-9
19. Pai R, Tarnawski AS. Signal transduction cascades triggered by EGF Receptor activation: relevance to gastric injury repair and ulcer healing. Dig Dis Sci 1998; 43 (9 Suppl.): 14S-22S
20. Szabo S, Vincze A. Growth factors in ulcer healing: lessons from recent studies. J Physiol (London) 2000; 94: 77-81
21. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS et al. Endostatin: An endogenous, inhibitor of angiogenesis and tumour growth. Cell 1997; 88: 277-85
22. Yamaguchi N, Anand-Apte B, Lee M, Sasaki T, Fukai N, Shapiro R et al. Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding. EMBO J 1999; 18: 4414-23
23. Dejana E, Lampugnani MG, Giorgi M, Gaboli M, Federici AB, Ruggeri ZM et al. Von Willebrand factor promotes endothelial cell adhesion via an Arg-Gly-Asp-dependent mechanism. J Cell Biol 1989; 109: 367-75
24. Ma L, Del Soldato P, Wallace L. Divergent effects of new cyclooxigenase inhibitors on gastric ulcer healing: shifting the angiogenic balance. Proc Natl Acad Sci USA 2002; 99: 13 243-7
25. Han JA, Ha KS, Kwon YG, Kim YM. Prostaglandin E2 stimulates angiogenesis by activating the nitric oxide/cGMP pathway in human umbilical vein endothelial cells. Exp Mol Med 2005; 37: 588-600
26. Schmassmann A, Peskar BM, Stettler C, Netzer P, Stroff T, Flogerzi B et al. Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats. Br J Pharmacol 1998; 123: 795-804
27. Miura S, Tatsuguchi A, Wada K, Takeyama H, Shinji Y, Hiratsuka T et al. Cyclooxygenase-2-regulated vascular endothelial growth factor release in gastric fibroblasts. Am J Physiol Gastrointest Liver Physiol 2004; 287: G444-G51
28. Ng KM, Cho CH, Chang FY, Luo JC, Lin HC, Lin HY et al. Omeprazole promotes gastric epithelial cell migration. J Pharm Pharmacol 2008; 60: 655-60